XPO1 and non-small cell lung carcinoma: Among the many genes that have been shown to be rearranged with ALK, there are currently no reports on the XPO1-ALK fusion in metastatic NSCLC, and there are no clear conclusions on whether using ALK-TKIs is effective or safe.